About 250 MG Crizonitib Capsules
250 MG Crizonitib Capsules are a medication formulated for oral administration, containing 250 mg of the active ingredient Crizotinib. These capsules are mainly used for the treatment of specific types of cancer, specifically non-small cell lung cancer (NSCLC) that is positive for an abnormal anaplastic lymphoma kinase (ALK) gene. 250 MG Crizonitib Capsules works best by inhibiting the activity of the abnormal ALK protein, which is responsible for promoting the growth and spread of cancer cells. By blocking this protein, Crizotinib helps to slow down or stop the progression of cancer.
FAQs of 250 MG Crizonitib Capsules:
Q: What type of drug are 250 MG Crizonitib Capsules classified as?
A: 250 MG Crizonitib Capsules are classified as an injection.
Q: What is the physical form of 250 MG Crizonitib Capsules?
A: The physical form of 250 MG Crizonitib Capsules is liquid.
Q: What dosage should be followed for 250 MG Crizonitib Capsules?
A: The dosage for 250 MG Crizonitib Capsules should be as per instructions.
Q: How should 250 MG Crizonitib Capsules be stored?
A: 250 MG Crizonitib Capsules should be stored in a dry place.
Q: What are the dosage guidelines for 250 MG Crizonitib Capsules?
A: The dosage guidelines for 250 MG Crizonitib Capsules are as per required.